Lv1
18 积分 2024-04-22 加入
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
4个月前
已完结
Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review
7个月前
已完结
Atrasentan in Patients with IgA Nephropathy
7个月前
已完结
Atrasentan in Patients with IgA Nephropathy
8个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
8个月前
已完结
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
9个月前
已完结
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
9个月前
已关闭
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
9个月前
已完结
Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
9个月前
已关闭
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency
10个月前
已完结
皖公网安备34019202002308
